Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Endothelium/vascular type/nitric oxide

Citations 191-200 of 1327 total displayed.

Past content (since Jan 1999):

Vascular Medicine
Proteasome-Dependent Degradation of Guanosine 5'-Triphosphate Cyclohydrolase I Causes Tetrahydrobiopterin Deficiency in Diabetes Mellitus
Jian Xu, Yong Wu, Ping Song, Miao Zhang, Shuangxi Wang, and Ming-Hui Zou
Circulation 2007;116:944-953; published online before print as doi:10.1161/CIRCULATIONAHA.106.684795 [Abstract] [Full text]  

Articles
In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography. Validation and Application in Nitric Oxide Synthase 3–Deficient Mice
Michael J. Raher, Hélène Thibault, Kian Keong Poh, Rong Liu, Elkan F. Halpern, Geneviève Derumeaux, Fumito Ichinose, Warren M. Zapol, Kenneth D. Bloch, Michael H. Picard, and Marielle Scherrer-Crosbie
Circulation published August 20, 2007, doi:10.1161/CIRCULATIONAHA.107.707737 [Abstract]  

Articles
Central Role of Calcium-Dependent Tyrosine Kinase PYK2 in Endothelial Nitric Oxide Synthase–Mediated Angiogenic Response and Vascular Function
Akihiro Matsui, Mitsuhiko Okigaki, Katsuya Amano, Yasushi Adachi, Denan Jin, Shinji Takai, Tomoya Yamashita, Seinosuke Kawashima, Tatsuya Kurihara, Mizuo Miyazaki, Kento Tateishi, Shinsaku Matsunaga, Asako Katsume, Shoken Honshou, Tomosaburo Takahashi, Satoaki Matoba, Tetsuro Kusaba, Tetsuya Tatsumi, and Hiroaki Matsubara
Circulation published August 13, 2007, doi:10.1161/CIRCULATIONAHA.106.645416 [Abstract]  

Articles
Proteasome-Dependent Degradation of Guanosine 5'-Triphosphate Cyclohydrolase I Causes Tetrahydrobiopterin Deficiency in Diabetes Mellitus
Jian Xu, Yong Wu, Ping Song, Miao Zhang, Shuangxi Wang, and Ming-Hui Zou
Circulation published August 6, 2007, doi:10.1161/CIRCULATIONAHA.106.684795 [Abstract]  

Molecular Cardiology
Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus: Restoration by the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone
Sajoscha A. Sorrentino, Ferdinand H. Bahlmann, Christian Besler, Maja Müller, Svenja Schulz, Nina Kirchhoff, Carola Doerries, Tibor Horváth, Anne Limbourg, Florian Limbourg, Danilo Fliser, Hermann Haller, Helmut Drexler, and Ulf Landmesser
Circulation 2007;116:163-173; published online before print as doi:10.1161/CIRCULATIONAHA.106.684381 [Abstract] [Full text]  

Vascular Medicine
L-Arginine Supplementation in Peripheral Arterial Disease: No Benefit and Possible Harm
Andrew M. Wilson, Randall Harada, Nandini Nair, Naras Balasubramanian, and John P. Cooke
Circulation 2007;116:188-195; published online before print as doi:10.1161/CIRCULATIONAHA.106.683656 [Abstract] [Full text]  

Cardiovascular Involvement in General Medical Conditions
Chronic Kidney Disease: Effects on the Cardiovascular System
Ernesto L. Schiffrin, Mark L. Lipman, and Johannes F.E. Mann
Circulation 2007;116:85-97, doi:10.1161/CIRCULATIONAHA.106.678342 [Abstract] [Full text]  

Correspondence
Letter by Krötz et al Regarding Article, "Improvement of Peripheral Endothelial Dysfunction by Protein Tyrosine Phosphatase Inhibitors in Heart Failure"
Florian Krötz, Hae-Young Sohn, and Hanna Mannell
Circulation 2007;115:e648, doi:10.1161/CIRCULATIONAHA.107.690354 [Full text]  

Correspondence
Response to Letter Regarding Article, "Improvement of Peripheral Endothelial Dysfunction by Protein Tyrosine Phosphatase Inhibitors in Heart Failure"
Magali Vercauteren, Elise Remy, Corinne Devaux, Brigitte Dautreaux, Jean-Paul Henry, Fabrice Bauer, Paul Mulder, Christian Thuillez, Vincent Richard, Rob Hooft van Huijsduijnen, and Agnès Bombrun
Circulation 2007;115:e649, doi:10.1161/CIRCULATIONAHA.107.695601 [Full text]  

Articles
Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus. Restoration by the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone
Sajoscha A. Sorrentino, Ferdinand H. Bahlmann, Christian Besler, Maja Müller, Svenja Schulz, Nina Kirchhoff, Carola Doerries, Tibor Horváth, Anne Limbourg, Florian Limbourg, Danilo Fliser, Hermann Haller, Helmut Drexler, and Ulf Landmesser
Circulation published June 25, 2007, doi:10.1161/CIRCULATIONAHA.106.684381 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133

* Subspecialty Collections Home

* Show  Endothelium/vascular type/nitric oxide
 collections from other journals.

* Related collections:
 Vascular biology
 Endothelium/vascular type/nitric oxide
 Mechanism of atherosclerosis/growth factors
 Smooth muscle proliferation and differentiation
 Other Vascular biology